About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Georgia | 322 Studies

Clinical Trials Prostate CancerGeorgia

Prostate Cancer Clinical Trials in Georgia

Find 322 clinical trials for prostate cancer near Georgia. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Georgia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 301-320 of 322 trials

Active not recruitingA Study of PARG Inhibitor IDE161 in Participants With Advanced Solid TumorsThe purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.NCT05787587·Phoenix, Arizona and 26 others CompletedEfficacy Study of ABR-215050 to Treat Prostate CancerTo investigate ABR-215050 as a possible treatment for prostate cancer.NCT00560482·Anchorage, Alaska and 64 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.This is a study using sunitinib for patients ending treatment on a previous sunitinib malate protocol to continue to receive sunitinib.NCT00428220·Atlanta, Georgia and 112 others

CompletedA Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid TumorsThis is a Phase I, open-label, multi-center, competitive enrollment and dose-escalation study of ALT-836 in combination with standard of care gemcitabine in participants who have…NCT01325558·Atlanta, Georgia and 3 others

TerminatedGenistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate CancerGenistein is a natural supplement that comes from soy.NCT02766478·Atlanta, Georgia

RecruitingA Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has SpreadThis study will test a study drug called BPX-601, a CAR-T cell product manufactured from the patient's own T-cells, to see if it can help treat advanced prostate cancer.NCT07543055·Atlanta, Georgia and 2 others

No longer availableRadium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone MetastasesThis study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC patients diagnosed with symptomatic bone…NCT01516762·Birmingham, Alabama and 59 others

CompletedSafety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)The purpose of this study is to assess the safety and activity of ARN-509 in men with advanced castration resistant prostate cancer.NCT01171898·San Diego, California and 14 others

RecruitingEvaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine TumorsThe objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung…NCT07080242·Huntsville, Alabama and 30 others

TerminatedMRI Guided Prostate Cancer Focal Laser AblationThe study is a prospective, single-arm, non-randomized, unblinded trial to determine the safety and efficacy of MRI guided focal laser ablation of localized low and intermediate…NCT03634579·Atlanta, Georgia

Active not recruitingA Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyThe purpose of this study is to determine if treatment with apalutamide plus androgen deprivation therapy (ADT) before and after radical prostatectomy (RP) with pelvic lymph node…NCT03767244·La Jolla, California and 202 others

RecruitingStudy Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPCThe purpose of this study is to determine whether \[225Ac\]Ac-PSMA-617 (AAA817), given for up to 6 cycles at a dose of 10 Megabecquerel (MBq) +/- 10%, plus androgen receptor…NCT06855277·Homewood, Alabama and 105 others

RecruitingA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsThe purpose of this study is to find out whether the study drug, LY4052031, is safe, tolerable and effective in participants with advanced, or metastatic solid tumors including…NCT06465069·Duarte, California and 39 others

TerminatedA Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate CancerEnthuse M0 is a large phase III clinical trial studying the efficacy of ZD4054 (Zibotentan) in hormone resistant prostate cancer (HRPC).NCT00626548·Tucson, Arizona and 321 others

CompletedStudy of Immunotherapy to Treat Advanced Prostate CancerThe purpose of the study is to determine if advanced prostate cancer patients that are treated with radiotherapy (RT) plus ipilimumab live longer that those treated with RT aloneNCT00861614·Mobile, Alabama and 157 others

CompletedA Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyThe purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene deficiency, respond to…NCT02952534·Birmingham, Alabama and 148 others

CompletedHormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate CancerRATIONALE: Androgens can stimulate the growth of prostate cancer cells. Drugs such as ketoconazole may stop the production of androgens.NCT00027859·Huntsville, Alabama and 97 others

RecruitingStudy of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid TumorsPhase I: Characterize safety and tolerability of GVV858 as a single agent and in combination with fulvestrant or letrozole.NCT07288359·Atlanta, Georgia and 15 others

CompletedPerioperative Post-Prostatectomy Incontinence Home Telehealth ProgramMany men develop urine leakage after prostate cancer surgery.NCT01960998·Birmingham, Alabama and 2 others

CompletedChemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00005847·Denver, Colorado and 18 others

PreviousPage 16 of 17Next

Other Conditions in Georgia

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma